Global Opioids Market : Size, Share, Trend and Forecast to 2021

Submitted by: Submitted by

Views: 10

Words: 5771

Pages: 24

Category: Business and Industry

Date Submitted: 05/06/2016 02:37 AM

Report This Essay

Global Opioids Market : Size, Share, Trend and Forecast

to 2021

Persistence Market Research

Global Opioids Market is anticipated to

exhibit a stable CAGR during the forecast

period, 2015 - 2021 - Persistence Market

Research

Persistence Market Research

1

Global Opioids Market : Size, Share, Trend and Forecast

to 2021

Persistence Market Research Released New Market Report “Global Market Study on Opioids:

Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the

Forecast Period”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast

period (2015-2021).

By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and

methadone. Morphine segment was the largest contributor in overall opioids market, accounting for

around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7%

during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative

growth opportunities in opioids market, owing to their potential application in opioid substitution treatment

and fewer side effects as compared to natural opioids. By application, the global opioids market is

segmented into analgesia, cough suppression, and diarrhea suppression. Analgesia segment comprises

numerous conditions namely, anesthesia, surgical pain, injury or trauma, cancer pain and pain arising

from diseases. The analgesia segment accounted for around 67% share in overall opioids market in 2014

and is expected to register fastest CAGR of 3.3% during the forecast period.

Interested in report: Please follow the below links to meet your requirements; Request for the

Report Sample: http://www.persistencemarketresearch.com/samples/3066

Global opioids market growth is mainly driven by increasing demand for opioids in non-cancer pain

management, rising geriatric populations suffering from terminal conditions, uncontrolled prescription of

opioids...